FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNyrada Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NYR.AX
Nyrada Inc. Stock AnalysisComprehensive stock analysis for Nyrada Inc. (NYR.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNYR.AX
NYR.AX
Nyrada Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NYR.AX
  1. Home
  2. Stocks
  3. Nyrada Inc.

Nyrada Inc.

🇦🇺NYR.AX•ASX

Nyrada Inc.

🇦🇺NYR.AX•ASX

Your view on NYR.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nyrada Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
James Bonnar
Headquarters
Sydney Place, Sydney, NSW, AU
Industry
Biotechnology
Sector
Healthcare
CEO
James Bonnar
Headquarters
Sydney Place, Sydney, NSW, AU
Description

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

Its lead candidate is Xolatryp, a small molecule drug which has completed phase 1 clinical trial for neuroprotection and cardioprotection indications and in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Nyrada Inc.. Starting points for Nyrada Inc.: EPS -AUD 0.03, beta 0.88 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Nyrada Inc.. Nyrada Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Nyrada Inc.. Trailing twelve-month EPS for Nyrada Inc. stands at -AUD 0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Nyrada Inc.. Nyrada Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NYR.AX20 companies
Compare NYR.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ACW.AXActinogen Medical LimitedHealthcareBiotechnology—
AGN.AXArgenica Therapeutics LtdHealthcareBiotechnology—
ALA.AXArovella Therapeutics LimitedHealthcareBiotechnology—
ATH.AXAlterity Therapeutics LimitedHealthcareBiotechnology—
IXC.AXInvex Therapeutics LtdHealthcareBiotechnology—
NEU.AXNeuren Pharmaceuticals LimitedHealthcareBiotechnology—
NSB.AXNeuroScientific Biopharmaceuticals LimitedHealthcareBiotechnology—
NTI.AXNeurotech International LimitedHealthcareBiotechnology—
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
ORGSOrgenesis Inc.HealthcareOTC$3.0M
ORICORIC Pharmaceuticals, Inc.HealthcareNASDAQ$795.1M
ORKAOruka Therapeutics, Inc.HealthcareNASDAQ$6.5B
ORMPOramed Pharmaceuticals Inc.HealthcareNASDAQ$169.2M
ORPOFOSE Immunotherapeutics S.A.HealthcareOTC$260.3M
ORYZFOryzon Genomics S.A.HealthcareOTC$283.9M
OSRHWOSR Holdings, Inc.HealthcareNASDAQ$7.8M
OSTXOS Therapies IncorporatedHealthcareAMEX$48.1M
OTLCOncotelic Therapeutics, Inc.HealthcareOTC$21.2M
OTLKOutlook Therapeutics, Inc.HealthcareNASDAQ$99.3M
OVIDOvid Therapeutics Inc.HealthcareNASDAQ$426.5M
OXBOFOxford BioDynamics PlcHealthcareOTC$4.3M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Nyrada Inc.. Coverage tracks Nyrada Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Nyrada Inc.

NYR.AX AnalysisFair
Past
5
Growth
1
Health
5
Profit
1
Value
1